Table 3.
Scoresa for the Immediate Treatment (IT) and Delayed Treatment (DT) Groups’ Baseline and 10-Week Follow-Up
| Baseline | IT Group 10-Week Follow-up | Difference | Baseline | DT Group 10-Week Follow-up | Difference | F-value | |
|---|---|---|---|---|---|---|---|
| WHO-DAS II | |||||||
| Communication | 21.58 (16.69) | 13.71 (13.17) | − 7.82* | 23.29 (15.48) | 26.19 (16.47) | 2.89* | 69.16* |
| Participation | 16.37 (17.93) | 14.12 (16.78) | − 2.25* | 16.85 (16.71) | 19.87 (18.65) | 3.02* | 15.66* |
| Total | 15.60 (15.59) | 12.70 (12.90) | − 2.90* | 15.99 (13.24) | 19.16 (15.99) | 3.17* | 38.33* |
| APHAB global | 47.63 (16.38) | 18.11 (−9.81) | − 29.53* | 47.02 (15.82) | 51.21 (15.30) | 4.19* | 538.25* |
| HHIE total | 41.42 (23.43) | 23.98 (23.41) | − 17.54* | 41.30 (21.46) | 43.07 (−22.12) | 1.77 | 86.41* |
WHO-DAS II = World Health Organization, Disability Assessment Schedule II; APHAB = Abbreviated Profile of Hearing Aid Benefit; HHIE = Hearing Handicap Inventory for the Elderly.
a
Means (standard deviations).
*
Significant differences in interactions from baseline to the 10-week follow-up at p <.01. Also shown are F-values for each interaction effect of the repeated-measures ANOVAs.